Lobbying

Wake Forest School of Medicine, Institute for Regenerative Medicine's latest lobbying report covers Q4 2024, at under $5,000. Its first report covers Q4 2022.

Wake Forest School of Medicine, Institute for Regenerative Medicine

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Wake Forest School of Medicine, Institute for Regenerative Medicine lobbying by quarter
Wake Forest School of Medicine, Institute for Regenerative Medicine lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

No issue reported.

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

No house or agency named.

Firms it paid

Firm
Stapleton & Associates$09 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/01/10for Q4 2024Stapleton & AssociatesUnder $5,000
24/10/09for Q3 2024Stapleton & AssociatesUnder $5,000
24/07/16for Q2 2024Stapleton & AssociatesUnder $5,000
24/04/08for Q1 2024Stapleton & AssociatesUnder $5,000
24/01/20for Q4 2023Stapleton & AssociatesUnder $5,000
23/10/17for Q3 2023Stapleton & AssociatesUnder $5,000
23/07/17for Q2 2023Stapleton & AssociatesUnder $5,000
23/04/17for Q1 2023Stapleton & AssociatesUnder $5,000
23/01/17for Q4 2022Stapleton & AssociatesUnder $5,000